Cargando…
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the Low‐HDL Phenotype
BACKGROUND: Low high‐density lipoprotein (HDL) levels are major predictors of cardiovascular (CV) events, even in patients on statin treatment with low‐density lipoprotein (LDL) at target. In animal models HDLs protect LDL from oxidation and blunt platelet activation. Our study aimed to examine whet...
Autores principales: | Vazzana, Natale, Ganci, Antonina, Cefalù, Angelo Baldassare, Lattanzio, Stefano, Noto, Davide, Santoro, Nicole, Saggini, Raoul, Puccetti, Luca, Averna, Maurizio, Davì, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647282/ https://www.ncbi.nlm.nih.gov/pubmed/23557750 http://dx.doi.org/10.1161/JAHA.113.000063 |
Ejemplares similares
-
Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases
por: Giammanco, Antonina, et al.
Publicado: (2021) -
Role of Nutraceuticals in Hypolipidemic Therapy
por: Barbagallo, Carlo M., et al.
Publicado: (2015) -
The pathophysiology of intestinal lipoprotein production
por: Giammanco, Antonina, et al.
Publicado: (2015) -
Lipoprotein Abnormalities in Chronic Kidney Disease and Renal Transplantation
por: Barbagallo, Carlo Maria, et al.
Publicado: (2021) -
Statin-induced autoimmune myositis: a proposal of an “experience-based” diagnostic algorithm from the analysis of 69 patients
por: Gagliardo, Carola Maria, et al.
Publicado: (2023)